March 3, 2026

Nanoparticle system shows promise for delivering mRNA to prevent type 1 diabetes

March 3, 2026 / Research update / InnovateMed Author / type 1 diabetes

by University of Chicago Medical Center edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Cell Reports Medicine (2026). DOI: 10.1016/j.xcrm.2026.102634 Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the […]

Nanoparticle system shows promise for delivering mRNA to prevent type 1 diabetes Read More »

Eye tests reveal brain trauma in veterans more than a decade after concussions

March 3, 2026 / Research update / InnovateMed Author / concussion

by University of Colorado Anschutz edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: CC0 Public Domain A study by researchers at the CU Anschutz Marcus Institute for Brain Health suggests that veterans with concussions may continue to show subtle but measurable brain function differences more than a decade after

Eye tests reveal brain trauma in veterans more than a decade after concussions Read More »

Natural anti-inflammatory protein could save lives of sepsis patients, mouse study suggests

March 3, 2026 / Research update / InnovateMed Author / sepsis

by University of Adelaide edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain A naturally occurring protein in the human body could protect people from one of the world’s biggest killers—sepsis. The protein’s ability to reduce inflammation in a preclinical study raises hopes that it could be

Natural anti-inflammatory protein could save lives of sepsis patients, mouse study suggests Read More »

Ultrasound-activated ‘nanoagents’ kill superbugs hiding in biofilms

March 3, 2026 / Research update / InnovateMed Author / biofilms

by University of Birmingham edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Abstract. Credit: JACS Au (2026). DOI: 10.1021/jacsau.5c01711 Scientists have designed nanoagents that act like smart drug-delivery capsules—carrying an antibiotic deep into bacterial infection sites and releasing it only when activated by gentle ultrasound. Delivering antibiotics locally, directly to the site

Ultrasound-activated ‘nanoagents’ kill superbugs hiding in biofilms Read More »

New diagnostic markers for multiple sclerosis discovered in cerebrospinal fluid

March 3, 2026 / Research update / InnovateMed Author / multiple sclerosis

by Christiane Menzfeld, Max Planck Society edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Next to brain imaging, laboratory analysis of cerebrospinal fluid is needed for the diagnosis of multiple sclerosis. Credit: TUM, adapted by MPIB Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered

New diagnostic markers for multiple sclerosis discovered in cerebrospinal fluid Read More »

Cell-free DNA offers early warning for bloodstream infections in kids with leukemia

March 3, 2026 / Clinical Practice / InnovateMed Author / leukemia

by St. Jude Children’s Research Hospital edited by Robert Egan Editors’ notes The GIST Add as preferred source Joshua Wolf, PhD, MBBS, St. Jude Department of Host-Microbe Interactions. Credit: St. Jude Children’s Research Hospital Researchers have identified a promising way to predict bloodstream infections in children with high-risk leukemia days before the infection would be diagnosed using

Cell-free DNA offers early warning for bloodstream infections in kids with leukemia Read More »

Ivermectin is making a post-pandemic comeback, among cancer patients

March 3, 2026 / Clinical Practice / InnovateMed Author / ivermectin

March 2, 20267:00 AM ET Yuki Noguchi 4-Minute Listen Transcript Nate Kitch for NPR MaryJo Perry raises animals on her property outside of Jackson, Miss., and uses ivermectin to treat her cattle. To her, the drug is as familiar, safe, cheap and effective as vitamins: “We’ve been using it on the farm for 40 years.”

Ivermectin is making a post-pandemic comeback, among cancer patients Read More »

Your AI glossary

March 3, 2026 / News update / InnovateMed Author / Al glossary

Illustration: Natalie Peeples/Axios AI is moving fast, and a wave of hot takes is fueling doomerism and amplifying fears about what tech could do to jobs, power and society, Axios’ Madison Mills writes. Why it matters: When something scares me, I like to focus on what I can control. In this case, that’s my own understanding of AI, as

Your AI glossary Read More »

Ultraprocessed foods are engineered like cigarettes

March 3, 2026 / Patient education / InnovateMed Author / processed food

By Dr. Liji Thomas, MDReviewed by Lauren HardakerMar 2 2026 If cigarettes were engineered for addiction, are some ultraprocessed foods following the same blueprint? A new analysis reveals how industry design strategies may be shaping modern diets, and why policymakers may need to respond. Study: From Tobacco to Ultraprocessed Food: How Industry Engineering Fuels the Epidemic of Preventable

Ultraprocessed foods are engineered like cigarettes Read More »

Cracking a ‘holy grail’ challenge in cancer cell therapy

March 3, 2026 / Research update / InnovateMed Author / cancer cell therapy

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they’ve been trying to engineer a cell that’s effective against solid tumors, which account for the vast majority of cancer cases. Yale scientists have engineered natural killer cells that eliminate solid tumors in mouse models. The study may lead to a simpler, “off

Cracking a ‘holy grail’ challenge in cancer cell therapy Read More »